Reader Response: Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Schrag et al.1 reported that Group A streptococcal (GAS) exposure is unrelated to tics in children at risk for tic disorders. The critical limitations of this study are that only children with genetic risks for tics were studied, and information about risk for autoimmunity, infection susceptibility, and antibiotics use is absent.1 The European Multicenter Tics in Children Study (EMTICS) home page states that many patients refused to participate when told that antibiotic use would be limited. This would introduce a negative selection bias against families who perceive themselves as high risk and patients procuring antibiotics outside the trial.2 GAS infections trigger autoimmune disorders through mechanisms mediated by superantigens and adaptive immunity.3 Studies in rodent models for GAS-induced neuropsychiatric symptoms showed that Th17 lymphocytes and autoantibodies, generated in response to multiple infections, targeted the brain and triggered neuroinflammation. They also caused blood-brain barrier damage and neuronal circuitry dysfunction, which elicited behavioral abnormalities.4 We have witnessed the transformative effect of antibiotic treatment in a small group of patients with Obsessive-Compulsive Disorder (OCD) and/or movement disorders secondary to GAS infections.5 Consequently, we are concerned that results from the EMTICS study may be incorrectly extrapolated to children and adolescents with acute onset of tics, resulting in effective treatment being withheld.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- Received July 7, 2022.
- Accepted in final form July 7, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg